GlassScriptPhysician profile
Brenna M Lee
NPI 1578019758
$1,294.98
in general payments reported to CMS, 2019-2025
20 companies · $395 in 2025
The $395 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $58.73 · 2022: $150 · 2023: $480 · 2024: $211 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $986 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $986.34 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $217.45 | 2022-2025 | Wakix |
| Philips North America LLC | $209.52 | 2021-2025 | (Ak6) Vest Therapy, Vest Therapy Und, Incourage Airway Clearance Therapy |
| Regeneron Healthcare Solutions, INC. | $119.21 | 2022-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $118.28 | 2022-2025 | Ofev, Jascayd |
| Astrazeneca Pharmaceuticals LP | $109.39 | 2022-2025 | Tezspire, Airsupra, Breztri |
| Genzyme Corporation | $106.87 | 2022-2025 | |
| Pulmonx Corporation | $82.99 | 2023 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Insmed, INC. | $57.17 | 2024-2025 | Arikayce |
| Amgen INC. | $39.79 | 2025 | Tezspire |
| Glaxosmithkline, LLC. | $38.55 | 2024-2025 | Nucala |
| Ethicon INC. | $27.28 | 2021 | |
| Inspire Medical Systems, INC. | $25.31 | 2023 | Inspire |
| United Therapeutics Corporation | $19.92 | 2025 | Tyvaso |
| Tactile Systems Technology INC | $19.53 | 2025 | Nimbl, Flexitouch Plus |
| Viatris Specialty LLC | $19.45 | 2025 | Yupelri |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $19.14 | 2024 | |
| Axsome Therapeutics, INC. | $17.28 | 2025 | Sunosi |
| Grifols USA, LLC | $17.05 | 2023 | Prolastin-C Liquid |
| Novo Nordisk INC | $15.84 | 2021 | |
| Lilly USA, LLC | $14.96 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brenna Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.